EA
IRMD icon

Ellsworth Advisors’s iRadimed IRMD Stock Holding History

Ellsworth Advisors’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05M Buy
11,177
+26
+0.2% +$2.37K 0.17% 112
2026
Q1 		$1.07M Sell
11,151
-661
-6% -$66.1K 0.2% 95
2025
Q4 		$1.21M Sell
11,812
-186
-2% -$16K 0.24% 94
2025
Q3 		$878K Sell
11,998
-132
-1% -$8.79K 0.19% 104
2025
Q2 		$725K Buy
12,130
+146
+1% +$8K 0.18% 109
2025
Q1 		$629K Buy
+11,984
New +$673K 0.17% 126
2024
Q1 		– Sell
-8,777
Closed -$417K – 188
2023
Q4 		$417K Buy
8,777
+209
+2% +$8.79K 0.13% 135
2023
Q3 		$337K Buy
8,568
+120
+1% +$5.58K 0.12% 139
2023
Q2 		$403K Buy
+8,448
New +$381K 0.14% 119

Other funds holding IRMD

SI
Shaker Investments Cleveland, Ohio $278M AUM 69.83% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
KPP
Kings Path Partners Sugar Land, Texas $376M AUM 19% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
1IA
1620 Investment Advisors Plymouth, Massachusetts $161M AUM 30.15% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Ellsworth Advisors's IRMD Position: Q2 2026 in Review

Ellsworth Advisors increased its iRadimed (IRMD) stake by 0.23% in Q2 2026, buying an estimated $2.37K and bringing the position to 11,177 shares worth $1.05M. The position accounts for 0.17% of the portfolio, ranked #112.

Ellsworth Advisors first reported a position in IRMD in Q2 2023 and has held it in 9 quarters since. The position peaked at $1.21M in Q4 2025. 18 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Ellsworth Advisors held 11,177 shares of iRadimed worth $1.05M as of Q2 2026.
  • Ellsworth Advisors bought 26 iRadimed shares in Q2 2026, an estimated $2.37K.
  • iRadimed made up 0.17% of Ellsworth Advisors's portfolio in Q2 2026, its #112 holding.
  • Ellsworth Advisors first reported a position in iRadimed in Q2 2023 and has held it in 9 quarters since.
  • Ellsworth Advisors's iRadimed position peaked at $1.21M in Q4 2025.
  • 18 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Ellsworth Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.